http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103288671-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-14
filingDate 2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2014-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103288671-B
titleOfInvention Synthetic method of (3S)-3-amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride
abstract The invention provides a synthetic method of an intermediate (3S)-3-amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride of an anti-hepatitis C new drug Telaprevir. The method comprises the following steps: carrying out (S)-N-benzyl-1-phenylethylamine addition and camphorsulfonyloxaziridine oxidation of a cheap raw material t-butyl sorbate to obtain chiral amine, carrying out t-butyl deprotection, carrying out condensation with cyclopropylamine to obtain amide, and carrying out hydrogenation reduction benzyl-deprotection to form hydrochloride in order to obtain (3S)-3-amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride. The method has the advantages of less reaction steps, short synthetic period and strong applicability.
priorityDate 2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010063252-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007022459-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007237818-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0218369-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393345
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410474654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65098
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482979
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411629853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163721077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450263420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414702879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450612600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465385426
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164010133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11084286
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69227945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18381240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457560897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1268085
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465806225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422071869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3010818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66656935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592

Total number of triples: 53.